Royalty Pharma plc — Director's Dealing 2022

Apr 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2022-03-31

Reporting Person: Fernandez Henry A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-31	Class A Ordinary Shares	A	964	$38.8703	Acquired	18900	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Ordinary Shares	58200	Indirect

Footnotes

F1: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.